Human Genome Epidemiology Literature Finder
Records 1 - 16 (of 16 Records) |
Query Trace: Neoplasms and MPL[original query] |
---|
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status. Thrombosis research 2016 Apr 140 Suppl 1 S183. Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden P E J, Swieringa F, Ten Cate H, Heemskerk J W M, Rambaldi A, Falanga |
Identification of Novel Oncogenic Mutations in Thyroid Cancer. Journal of the American College of Surgeons 2016 Jan . Pitt Susan C, Hernandez Roland A, Nehs Matthew A, Gawande Atul A, Moore Francis D, Ruan Daniel T, Cho Nancy |
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms. Medical oncology (Northwood, London, England) 2017 May 34 (5): 83. Chang Yu-Cheng, Lin Huan-Chau, Chiang Yi-Hao, Chen Caleb Gon-Shen, Huang Ling, Wang Wei-Ting, Cheng Chun-Chia, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chen Shu-Jen, Lim Ken-Hong, Kuo Yuan-Y |
Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma. Familial cancer 2018 7 17 (4): 569-576. Hylebos Marieke, Op de Beeck Ken, van den Ende Jenneke, Pauwels Patrick, Lammens Martin, van Meerbeeck Jan P, Van Camp G |
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India. Indian journal of pathology & microbiology 0 61 (2): 209-213. Rabade Nikhil, Subramanian P G, Kodgule Rohan, Raval Goutham, Joshi Swapnali, Chaudhary Shruti, Mascarenhas Russel, Tembhare Prashant, Gujral Sumeet, Patkar Nikh |
Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
Classification and Personalized Prognosis in Myeloproliferative Neoplasms. The New England journal of medicine 2018 10 379 (15): 1416-1430. Grinfeld Jacob, Nangalia Jyoti, Baxter E Joanna, Wedge David C, Angelopoulos Nicos, Cantrill Robert, Godfrey Anna L, Papaemmanuil Elli, Gundem Gunes, MacLean Cathy, Cook Julia, O'Neil Laura, O'Meara Sarah, Teague Jon W, Butler Adam P, Massie Charlie E, Williams Nicholas, Nice Francesca L, Andersen Christen L, Hasselbalch Hans C, Guglielmelli Paola, McMullin Mary F, Vannucchi Alessandro M, Harrison Claire N, Gerstung Moritz, Green Anthony R, Campbell Peter |
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. Molecular cancer therapeutics 2019 4 18 (6): 1149-1157. Janku Filip, Diamond Eli L, Goodman Aaron M, Raghavan Vaijayanthi Kandadai, Barnes Tamara G, Kato Shumei, Abdel-Wahab Omar, Durham Benjamin H, Meric-Bernstam Funda, Kurzrock Razel |
Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing. Frontiers in oncology 2019 3 9 123. Wang Yao, Yu Mei, Yang Jia-Xin, Cao Dong-Yan, Zhang Ying, Zhou Hui-Mei, Yuan Zhen, Shen Ke |
Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast Cancer. The oncologist 2021 Jul . Al-Shamsi Humaid O, Abu-Gheida Ibrahim, Abdulsamad Ahmed S, AlAwadhi Aydah, Alrawi Sadir, Musallam Khaled M, Arun Banu, Ibrahim Nuhad |
Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia. Cancer 2022 11 129 (2): 245-254. Han Haohao, Yao Yifang, Wang Hong, Zhou Meng, Zhang Ziyan, Xu Xiaoyan, Qi Jiaqian, Liu Yuejun, Wu Depei, Han Y |
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 2022 Oct . Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio |
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR. Cancer medicine 2024 4 13 (7): e7123. Zhanlong Wang, Xin Tian, Jinyu Ma, Yuhui Zhang, Wenru Ta, Yifan Duan, Fengli Li, Hong Zhang, Long Chen, Shaobin Yang, Enbin Liu, Yani Lin, Weiping Yuan, Kun Ru, Jie B |
- Page last reviewed:Feb 1, 2024
- Content source: